Medican Enterprises (OTCMKTS:MDCN) & Newmark Group (NASDAQ:NMRK) Head-To-Head Contrast

Medican Enterprises (OTCMKTS:MDCN) and Newmark Group (NASDAQ:NMRK) are both real estate companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings.

Analyst Ratings

This is a summary of recent ratings and target prices for Medican Enterprises and Newmark Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medican Enterprises	0	0	0	0	N/A
Newmark Group	0	0	3	0	3.00

Newmark Group has a consensus price target of $16.17, suggesting a potential upside of 6.92%.

Profitability

This table compares Medican Enterprises and Newmark Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medican Enterprises	N/A	N/A	N/A
Newmark Group	1.75%	17.78%	6.05%

Insider and Institutional Ownership

58.4% of Newmark Group shares are held by institutional investors. 2.9% of Medican Enterprises shares are held by company insiders. Comparatively, 31.8% of Newmark Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Medican Enterprises and Newmark Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medican Enterprises	N/A	N/A	N/A	($1.34)	N/A
Newmark Group	$2.54 billion	1.03	$42.58 million	$0.22	68.73

Newmark Group has higher revenue and earnings than Medican Enterprises. Medican Enterprises is trading at a lower price-to-earnings ratio than Newmark Group, indicating that it is currently the more affordable of the two stocks.

Summary

Newmark Group beats Medican Enterprises on 9 of the 9 factors compared between the two stocks.

About Medican Enterprises

Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.

About Newmark Group

Newmark Group, Inc. provides commercial real estate services in the United States, the United Kingdom, and internationally. The company offers capital markets consisting of investment sales and commercial mortgage brokerage; landlord or agency representation leasing; valuation and advisory; property management; commercial real estate technology platform and capabilities; the United Kingdom business rates services; due diligence, consulting, and other advisory services; GSEs and the Federal Housing Administration lending services comprising multifamily lending and loan servicing; asset management; and flexible workspace solutions for owners. It also provides tenant representation leasing; and global corporate services consisting of workplace and occupancy strategy, energy and sustainability services, technology, project management, real estate and lease administration, and facilities management. The company offers its services to commercial real estate tenants, investors, owners, occupiers, and developers; lenders; small and medium size businesses; and multi-national corporations. The company was formerly known as Newmark Grubb Knight Frank Capital Group and changed its name to Newmark Group, Inc. in October 2017. Newmark Group, Inc. was founded in 1929 and is based in New York, New York. Newmark Group, Inc.operates is a subsidiary of Cantor Fitzgerald, L.P.